New CEO to launch Azanta's product all over Europe

Danish pharmaceutical company Azanta has appointed a new CEO. His main task is to pave the way to the European market for Azanta's drug, which the company already launched in some countries by use of untraditional methods.

Azantas new CEO, Christian Gunni Pedersen (right) together with Medical Director, John Stone (center), and Director of Regulatory Affairs, Eileen Smits. Photo: Azanta

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles